Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing Wesolowsk LG et al AIDS 2006, 20:1661–1666
Voluntary Rapid Human Immunodeficiency Virus (HIV) Testing in Jails MacGowan R et al Sexually Transmitted Diseases, February Supplement 2009, Vol. 36, No. 2, p.S-9-S1
Diagnostic Accuracy of Two Oral Mucosal Fluid Based Tests for HIV Surveillance in Namibia Hamers RL et al Journal of Immune Deficiency Syndrome (JAIDS), Vol. 48, Number 1, May 1, 2008
Routine HIV Screening in the Emergency Department Using the New US Centers for Disease Control and Prevention Guidelines: Results From a High-Prevalence Area Brown J et al JAIDS, Vol. 46, Number 4, December 1, 2007
Detecting Unsuspected HIV Infection with a Rapid Whole-Blood HIV Test in an Urban Emergency DepartmentLyss SB et al JAIDS, Volume 00, Number 0, 2007
Rapid Human Immunodeficiency Virus-1 Testing on Labor and Delivery in 17 US Hospitals: The MIRIAD Experience Jamieson DJ et al American Journal of Obstetrics & Gynecology, Supplement to September 2007
Comparative Evaluation of Rapid HIV Antibody Tests Chen LS et al Point of Care, Vol. 6, No. 2, June 2007, p. 109-111
Evaluation of Diagnostic Accuracy, Feasibility and Client Preference for Rapid Oral Fluid-Based Diagnosis of HIV Infection in Rural India Pai NP et al PLOs ONE, Apr. 2007, Issue 4, e367
Performance of an Oral Fluid Rapid HIV-1/2 Test: Experience From Four CDC Studies Delaney KP et al AIDS 2006, Vol. 20 No. 12, p 1655-1660
Usefulness of a Rapid Human Immunodeficiency Virus-1 Antibody Test for Management of Occupational Exposure to Blood and Body Fluid Landrum ML et al Infection Control and Hospital Epidemiology, Sept. 2005, p-768-774
The Role of Rapid vs. Conventional Human Immunodeficiency Virus Testing for Inpatients-Effects on Quality Care Rubelchek R et al Archives of Internal Medicine, Vol. 165, Sept. 26, 2005
Evaluation of a Rapid Test for the Detection of Antibodies to Human Immunodeficiency Virus Type 1 and 2 in the Setting of Multiple Transmitted Viral Subtypes Reynolds SJ et al International Journal of STD & AIDS, 13:d498.1-3, 2002.
Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay Gürtler L et al. . J Virol Meth 1998;75:27–38.
Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test. Brust S et al J Virol Meth 2000; 90:153–65.
Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. Marks G et al AIDS 2006;20:1447–50.
HIV-1 transmission, by stage of infection. Hollingsworth TD et al J Infect Dis. 2008 Sep 1;198(5):687–93
Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. Pilcher CD et al. AIDS. 2007 Aug 20;21(13):1723–30
Brief but efficient: acute HIV infection and the sexual transmission of HIV. Quest Study; Duke-UNC-Emory Acute HIV Consortium. Pilcher CD et al JID. 2004 May 15;189(10):1785–92.
Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. Rosenberg NE et al J Infect Dis. 2012 Feb 15;205(4):528-34. Epub 2011 Dec 29.
Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme. Taegtmeyer M PLoS ONE 6(11): e28019. doi:10.1371/journal.pone.0028019
Benefit of the rapid test Determine HIV1/2 in the clinical diagnosis of HIV infection in Ibn Rochd hospital of Casablanca, Morocco.Ouladlahsen A et al Rev Epidemiol Sante Publique. 2012 Jul 10. [Epub ahead of print]
Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting Juliette Pavie1,PLoS ONE | ww.plosone.org July 2010 | Volume 5 | Issue 7 | e11581
Determine® HIV-1/2 Ag/Ab Combo:a revolutionary fourth generation rapid HIV test. Performance data review. Alere Healthcare.
Evaluation of the Rapid Immunoassay Determine HIV 1/2 for Detection of Antibodies to Human Immunodeficiency Virus Types 1 and 2. G. E. L. van den Berk, J ClinMicrobiol. 2003 August; 41(8): 3868–3869.
BASHH Clinical Governance Committee Guidance on the appropriate use of HIV Point of Care Tests Winter AJ et al
Diagnostic Testing for HIV Type 1 RNA in Seronegative Blood Ritter D et al, Am J Clin Pathol 2000;113:128–134
Evaluation of DETERMINE HIV-1/2 Ag/Ab COMBO HPA South East Regional Laboratory,April 2009 Jane Newman J et al, HPA Southampton, Virology Dept
BASHH Statement on HIV window period 15th March 2010